ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,018.39
-0.34%
US Tech 100
17,001.60
0.84%
다우존스 지수
37,903.29
0.00%
Bitcoin
58,797.38
0.96%
Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 영국
  5. LSE
  6. Idorsia Ltd (0RQE)

  7. Idorsia Ltd (0RQE) 뉴스

0RQE Idorsia Ltd

1.9775
0.00 (0.00%)
최종 업데이트: 09:00:00
15분 지연
기업명 주식 심볼 시장 주식 타입
Idorsia Ltd 0RQE 런던 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
Upgrade Icon
0.00 0.00% 1.9775 09:00:00
개장가 저가 고가 종가 전일 종가
1.9775
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
02/05/202401:00UKREGIdorsia increases the consent fee in connection with the..
02/05/202401:00UKREGIdorsia increases the consent fee in connection with the..
26/04/202414:00UKREGJERAYGO (aprocitentan) recommended for approval in Europe..
26/04/202414:00UKREGJERAYGO (aprocitentan) recommended for approval in Europe..
23/04/202414:00UKREGIdorsia publishes an invitation to a bondholder meeting
23/04/202414:00UKREGIdorsia publishes an invitation to a bondholder meeting
17/04/202414:00UKREGIdorsia publishes a Financial Status required for an..
17/04/202414:00UKREGIdorsia publishes a Financial Status required for an..
11/04/202414:00UKREGIdorsia takes steps to address short-term liquidity needs
11/04/202414:00UKREGIdorsia takes steps to address short-term liquidity needs
22/03/202415:00UKREGIdorsia thanks Guy Braunstein for his years of service as he..
22/03/202415:00UKREGIdorsia thanks Guy Braunstein for his years of service as he..
20/03/202415:00UKREGUS FDA approves Idorsia’s once-daily TRYVIO (aprocitentan) –..
20/03/202415:00UKREGUS FDA approves Idorsia’s once-daily TRYVIO (aprocitentan) –..
18/03/202415:00UKREGIdorsia and Viatris successfully close the transaction for..
18/03/202415:00UKREGIdorsia and Viatris successfully close the transaction for..
28/02/202415:00UKREGIdorsia and Viatris enter into a significant global research..
28/02/202415:00UKREGIdorsia and Viatris enter into a significant global research..
10/01/202415:00GLOBEIdorsia presents at the J.P. Morgan Healthcare Conference –..
04/11/202306:30GLOBENew Phase 3 data with aprocitentan for patients with..
24/10/202314:00GLOBEIdorsia announces financial results for the first nine..
23/10/202314:00GLOBEIdorsia is committed to further the science of sleep with a..
18/10/202300:45GLOBEInvitation to Idorsia's Nine-Month 2023 Financial Reporting..
06/09/202314:00GLOBEIdorsia reacquires the world-wide rights to aprocitentan
25/07/202314:00GLOBEIdorsia announces financial results for the first half 2023..
21/07/202314:00GLOBEIdorsia announces a cost reduction initiative to be..
20/07/202315:30GLOBEIdorsia sells its Asia Pacific (ex-China) operations –..
19/07/202300:45GLOBEInvitation to Idorsia's HY 2023 Financial Results webcast..
10/07/202314:00GLOBEIdorsia announces its insomnia medication, QUVIVIQ..
27/06/202300:45GLOBENew Phase 3 data with aprocitentan for patients with..
24/06/202300:45GLOBENew Phase 3 data with aprocitentan to be presented at the..
20/06/202314:00GLOBEIdorsia has secured bridge financing in the amount of CHF..
12/06/202314:00GLOBEIdorsia launches QUVIVIQ (daridorexant) in Switzerland – a..
06/06/202314:00GLOBEIdorsia has entered into exclusive negotiations with regard..
30/05/202314:00GLOBEIdorsia announces a change to commercial leadership
04/05/202318:16GLOBEIdorsia holds its Annual General Meeting of Shareholders
03/05/202314:00GLOBEHealth Canada approves QUVIVIQ (daridorexant) for the..

최근 히스토리

LSE
0RQE
Idorsia
Delayed Upgrade Clock
ADVFN Logo

대한변국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유